Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Randomized trial
Abstract
In a double-blind, placebo-controlled study, microdosing with psilocybin mushrooms (Psilocybe) produced sub-perceptual effects on mood and cognition, with some changes attributable to expectation, contributing to the evidence base on low-dose psilocybin-mushroom use.
Referenced for these plants
How to cite
Cavanna, F., Muller, S., de la Fuente, L.A., Zamberlan, F. and others (2022) 'Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study', Translational Psychiatry, 12(1), pp. 307. doi:10.1038/s41398-022-02039-0
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.